T1	PROC 46 77	Estudio de eficacia y seguridad
T2	DISO 130 160	cáncer de próstata metastásico
T3	PROC 177 187	castración
#1	AnnotatorNotes T3	C0007344; Castration; Therapeutic or Preventive Procedure
T4	PROC 216 229	quimioterapia
#2	AnnotatorNotes T4	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T5	PROC 252 292	Estudio Fase 2 aleatorizado, doble ciego
T6	CHEM 297 307	ipilimumab
#3	AnnotatorNotes T6	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T7	DISO 381 411	cáncer de próstata metastásico
T8	PROC 428 438	castración
#4	AnnotatorNotes T8	C0007344; Castration; Therapeutic or Preventive Procedure
T9	DISO 439 452	asintomáticos
#5	AnnotatorNotes T9	C0231221; Asymptomatic; Finding
T10	DISO 459 480	mínima sintomatología
#6	AnnotatorNotes T10	C3846033; Minimal signs/symptoms; Finding
T11	PROC 511 524	quimioterapia
#7	AnnotatorNotes T11	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T12	ANAT 552 558	sangre
#8	AnnotatorNotes T12	C0005767; Blood; Body Substance
T13	DISO 613 631	Cáncer de próstata
#9	AnnotatorNotes T13	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T14	DISO 658 688	Cáncer de próstata metastásico
T15	PROC 705 715	castración
#10	AnnotatorNotes T15	C0007344; Castration; Therapeutic or Preventive Procedure
T16	PROC 757 770	quimioterapia
#11	AnnotatorNotes T16	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T17	DISO 799 832	Cáncer de próstata con metástasis
T18	DISO 838 856	cáncer de próstata
#12	AnnotatorNotes T18	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T19	PROC 882 892	castración
#13	AnnotatorNotes T19	C0007344; Castration; Therapeutic or Preventive Procedure
T20	PROC 917 933	terapia hormonal
#14	AnnotatorNotes T20	C0279025; Hormone Therapy; Therapeutic or Preventive Procedure
T21	PROC 942 951	protocolo
#15	AnnotatorNotes T21	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T22	DISO 1049 1070	Metástasis viscerales
T23	ANAT 1080 1089	hepáticas
#16	AnnotatorNotes T23	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T24	ANAT 1091 1101	pulmonares
#17	AnnotatorNotes T24	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T25	ANAT 1104 1114	cerebrales
#18	AnnotatorNotes T25	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T26	PROC 1118 1129	Tratamiento
#19	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	PROC 1151 1164	inmunoterapia
#20	AnnotatorNotes T27	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T28	DISO 1173 1191	cáncer de próstata
#21	AnnotatorNotes T28	C0376358; Malignant neoplasm of prostate; Neoplastic Process
T29	PROC 1194 1212	Terapia citotóxica
T30	DISO 1241 1271	cáncer de próstata metastásico
T31	DISO 1298 1347	Función hematológica, renal o hepática inadecuada
T32	DISO 1274 1295	Enfermedad autoinmune
#22	AnnotatorNotes T32	C0004364; Autoimmune Diseases; Disease or Syndrome
T33	ANAT 1320 1325	renal
#23	AnnotatorNotes T33	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T34	ANAT 1328 1336	hepática
#24	AnnotatorNotes T34	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T35	PROC 1355 1364	protocolo
#25	AnnotatorNotes T35	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T36	ANAT 140 148	próstata
#26	AnnotatorNotes T36	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T37	ANAT 391 399	próstata
#27	AnnotatorNotes T37	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T38	PROC 540 558	muestras de sangre
#28	AnnotatorNotes T38	C0005834; Collection of blood specimen for laboratory procedure; Diagnostic Procedure | C1277698; Blood sample taken; Laboratory Procedure
T39	ANAT 623 631	próstata
#29	AnnotatorNotes T39	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T40	ANAT 668 676	próstata
#30	AnnotatorNotes T40	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T41	ANAT 809 817	próstata
#31	AnnotatorNotes T41	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T42	ANAT 848 856	próstata
#32	AnnotatorNotes T42	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T43	CHEM 925 933	hormonal
#33	AnnotatorNotes T43	C0019932; Hormones; Hormone
T44	ANAT 1060 1070	viscerales
#34	AnnotatorNotes T44	C0042779; Viscera; Body Part, Organ, or Organ Component
T45	ANAT 1183 1191	próstata
#35	AnnotatorNotes T45	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T46	ANAT 1251 1259	próstata
#36	AnnotatorNotes T46	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T47	PROC 191 199	tratados
#37	AnnotatorNotes T47	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T48	PROC 486 494	tratados
#38	AnnotatorNotes T48	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T49	PROC 732 740	tratados
#39	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	Date 13 17	2014
T51	Dose 81 88	3 mg/kg
T52	Dose 98 106	10 mg/kg
T54	LIVB 110 125	sujetos adultos
#40	AnnotatorNotes T54	C0681850; Study Subject; Group + C0001675; Adult; Age Group
T55	Neg_cue 188 190	no
T56	Dose 332 339	3 mg/kg
T57	Dose 349 357	10 mg/kg
T58	LIVB 361 376	sujetos adultos
#41	AnnotatorNotes T58	C0681850; Study Subject; Group + C0001675; Adult; Age Group
T60	Neg_cue 483 485	no
T61	LIVB 719 728	pacientes
#42	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	Neg_cue 729 731	no
T53	PROC 564 579	farmacogenética
#43	AnnotatorNotes T53	C3494710; Pharmacogenetic consultation; Health Care Activity (?)
A1	Population_data T54 Age
A3	Assertion T4 Negated
A4	Population_data T58 Age
A6	Assertion T11 Negated
A7	Assertion T9 Negated
A8	Assertion T49 Negated
A9	Assertion T16 Negated
A11	Status T4 History_of
A12	Status T11 History_of
A13	Status T16 History_of
A2	Status T26 History_of
A5	Status T27 History_of
A10	Status T29 History_of
A14	Status T47 History_of
A15	Assertion T47 Negated
A16	Status T48 History_of
A17	Assertion T48 Negated
A18	Status T49 History_of
#44	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#45	AnnotatorNotes T5	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#46	AnnotatorNotes T2	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#47	AnnotatorNotes T7	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#48	AnnotatorNotes T14	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#49	AnnotatorNotes T17	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#50	AnnotatorNotes T30	C0936223; Metastatic Prostate Carcinoma; Neoplastic Process
#51	AnnotatorNotes T22	C4725861; Secondary malignant neoplasm of viscera; Neoplastic Process 
#52	AnnotatorNotes T29	C0677881; Cytotoxic Chemotherapy; Therapeutic or Preventive Procedure 
R1	Experiences Arg1:T54 Arg2:T2	
R2	Location_of Arg1:T36 Arg2:T2	
T59	Observation 161 187	resistente a la castración
#53	AnnotatorNotes T59	C4329620; Castration Resistance; Finding
R3	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T59	
T63	Observation 412 438	resistente a la castración
#54	AnnotatorNotes T63	C4329620; Castration Resistance; Finding
R4	Location_of Arg1:T37 Arg2:T7	
R6	Experiences Arg1:T54 Arg2:T3	
R8	Negation Arg1:T55 Arg2:T47	
R9	Negation Arg1:T55 Arg2:T4	
R10	Experiences Arg1:T54 Arg2:T47	
R11	Experiences Arg1:T54 Arg2:T4	
R12	Has_Dose_or_Strength Arg1:T6 Arg2:T56	
R13	Has_Dose_or_Strength Arg1:T6 Arg2:T57	
R14	Experiences Arg1:T58 Arg2:T6	
R15	Experiences Arg1:T58 Arg2:T7	
R17	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T63	
R18	Experiences Arg1:T58 Arg2:T8	
R20	Experiences Arg1:T58 Arg2:T9	
R21	Overlap Arg1:T63 Arg2:T9	
R22	Overlap Arg1:T7 Arg2:T9	
R23	Experiences Arg1:T58 Arg2:T10	
R24	Causes Arg1:T7 Arg2:T10	
R25	Overlap Arg1:T63 Arg2:T10	
R26	Negation Arg1:T60 Arg2:T48	
R27	Negation Arg1:T60 Arg2:T11	
R28	Experiences Arg1:T58 Arg2:T48	
R29	Experiences Arg1:T58 Arg2:T11	
R31	Before Arg1:T38 Arg2:T53	
R32	Location_of Arg1:T39 Arg2:T13	
R33	Location_of Arg1:T40 Arg2:T14	
T64	Observation 689 715	resistente a la castración
#55	AnnotatorNotes T64	C4329620; Castration Resistance; Finding
R34	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T64	
R36	Experiences Arg1:T61 Arg2:T14	
R38	Experiences Arg1:T61 Arg2:T15	
R39	Experiences Arg1:T61 Arg2:T49	
R40	Negation Arg1:T62 Arg2:T49	
R41	Negation Arg1:T62 Arg2:T16	
R42	Experiences Arg1:T61 Arg2:T16	
R43	Location_of Arg1:T41 Arg2:T17	
R44	Location_of Arg1:T42 Arg2:T18	
T65	Observation 866 892	resistente a la castración
R45	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T65	
R47	Used_for Arg1:T43 Arg2:T20	
T66	Observation 895 905	Progresión
#56	AnnotatorNotes T66	C1457868; Worse; Finding (?)
R48	Overlap Arg1:T66 Arg2:T20	
R49	Location_of Arg1:T44 Arg2:T22	
R50	Location_of Arg1:T23 Arg2:T22	
R51	Location_of Arg1:T24 Arg2:T22	
R52	Location_of Arg1:T25 Arg2:T22	
R53	Location_of Arg1:T45 Arg2:T28	
R54	Location_of Arg1:T46 Arg2:T30	
T67	Quantifier_or_Qualifier 1222 1232	continuada
#57	AnnotatorNotes T67	C0549178; Continuous; Idea or Concept
R55	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T67	
R56	Location_of Arg1:T33 Arg2:T31	
R57	Location_of Arg1:T34 Arg2:T31	
#58	AnnotatorNotes T65	C4329620; Castration Resistance; Finding
A19	Experiencer T61 Patient
A20	Experiencer T54 Patient
A21	Experiencer T58 Patient
